100 related articles for article (PubMed ID: 38725139)
1. Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia.
Deng M; Cao J; van der Kroft G; van Dijk DPJ; Aberle MR; Grgic A; Neumann UP; Wiltberger G; Balluff B; Schaap FG; Heeren RMA; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2024 May; ():. PubMed ID: 38725139
[TBL] [Abstract][Full Text] [Related]
2. High levels of modified ceramides are a defining feature of murine and human cancer cachexia.
Morigny P; Zuber J; Haid M; Kaltenecker D; Riols F; Lima JDC; Simoes E; Otoch JP; Schmidt SF; Herzig S; Adamski J; Seelaender M; Berriel Diaz M; Rohm M
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1459-1475. PubMed ID: 33090732
[TBL] [Abstract][Full Text] [Related]
3. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia.
Deng M; Aberle MR; van Bijnen AAJHM; van der Kroft G; Lenaerts K; Neumann UP; Wiltberger G; Schaap FG; Olde Damink SWM; Rensen SS
Front Immunol; 2023; 14():1159411. PubMed ID: 37006254
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients.
Ubachs J; Ziemons J; Soons Z; Aarnoutse R; van Dijk DPJ; Penders J; van Helvoort A; Smidt ML; Kruitwagen RFPM; Baade-Corpelijn L; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2007-2021. PubMed ID: 34609073
[TBL] [Abstract][Full Text] [Related]
5. Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study.
Cala MP; Agulló-Ortuño MT; Prieto-García E; González-Riano C; Parrilla-Rubio L; Barbas C; Díaz-García CV; García A; Pernaut C; Adeva J; Riesco MC; Rupérez FJ; Lopez-Martin JA
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):348-357. PubMed ID: 29464940
[TBL] [Abstract][Full Text] [Related]
6. Pectoralis major muscle atrophy is associated with mitochondrial energy wasting in cachectic patients with gastrointestinal cancer.
Dolly A; Lecomte T; Tabchouri N; Caulet M; Michot N; Anon B; Chautard R; Desvignes Y; Ouaissi M; Fromont-Hankard G; Dumas JF; Servais S
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1837-1849. PubMed ID: 35316572
[TBL] [Abstract][Full Text] [Related]
7. A novel orthotopic mouse model replicates human lung cancer cachexia.
van de Worp WRPH; Theys J; González AS; van der Heyden B; Verhaegen F; Hauser D; Caiment F; Smeets HJM; Schols AMWJ; van Helvoort A; Langen RCJ
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1410-1423. PubMed ID: 37025071
[TBL] [Abstract][Full Text] [Related]
8. Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation.
Naumann P; Eberlein J; Farnia B; Liermann J; Hackert T; Debus J; Combs SE
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31717736
[TBL] [Abstract][Full Text] [Related]
9. Derangements of amino acids in cachectic skeletal muscle are caused by mitochondrial dysfunction.
Kunzke T; Buck A; Prade VM; Feuchtinger A; Prokopchuk O; Martignoni ME; Heisz S; Hauner H; Janssen KP; Walch A; Aichler M
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):226-240. PubMed ID: 31965747
[TBL] [Abstract][Full Text] [Related]
10. Motor protein function in skeletal abdominal muscle of cachectic cancer patients.
Taskin S; Stumpf VI; Bachmann J; Weber C; Martignoni ME; Friedrich O
J Cell Mol Med; 2014 Jan; 18(1):69-79. PubMed ID: 24251822
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylethanolamine (18:2e/18:2) may inhibit adipose tissue wasting in patients with cancer cachexia by increasing lysophosphatidic acid receptor 6.
Ding Z; Han J; Huang Q; Liu X; Sun D; Sui X; Zhuang Q; Wu G
Nutrition; 2024 Apr; 120():112356. PubMed ID: 38354460
[TBL] [Abstract][Full Text] [Related]
12. Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival.
Judge SM; Nosacka RL; Delitto D; Gerber MH; Cameron ME; Trevino JG; Judge AR
JNCI Cancer Spectr; 2018 Jul; 2(3):pky043. PubMed ID: 30637373
[TBL] [Abstract][Full Text] [Related]
13. Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice.
Baltgalvis KA; Berger FG; Peña MM; Mark Davis J; White JP; Carson JA
J Appl Physiol (1985); 2010 Oct; 109(4):1155-61. PubMed ID: 20651218
[TBL] [Abstract][Full Text] [Related]
14. Myokines in treatment-naïve patients with cancer-associated cachexia.
de Castro GS; Correia-Lima J; Simoes E; Orsso CE; Xiao J; Gama LR; Gomes SP; Gonçalves DC; Costa RGF; Radloff K; Lenz U; Taranko AE; Bin FC; Formiga FB; de Godoy LGL; de Souza RP; Nucci LHA; Feitoza M; de Castro CC; Tokeshi F; Alcantara PSM; Otoch JP; Ramos AF; Laviano A; Coletti D; Mazurak VC; Prado CM; Seelaender M
Clin Nutr; 2021 Apr; 40(4):2443-2455. PubMed ID: 33190987
[TBL] [Abstract][Full Text] [Related]
15. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia.
Vaes RDW; van Dijk DPJ; Welbers TTJ; Blok MJ; Aberle MR; Heij L; Boj SF; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1509-1524. PubMed ID: 33047901
[TBL] [Abstract][Full Text] [Related]
16. 2-Deoxy-D-glucose Alleviates Cancer Cachexia-Induced Muscle Wasting by Enhancing Ketone Metabolism and Inhibiting the Cori Cycle.
Wei L; Wang R; Wazir J; Lin K; Song S; Li L; Pu W; Zhao C; Wang Y; Su Z; Wang H
Cells; 2022 Sep; 11(19):. PubMed ID: 36230949
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice.
Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S
Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein levels and vitamin d receptor polymorphisms as markers in predicting cachectic syndrome in cancer patients.
Punzi T; Fabris A; Morucci G; Biagioni P; Gulisano M; Ruggiero M; Pacini S
Mol Diagn Ther; 2012 Apr; 16(2):115-24. PubMed ID: 22497530
[TBL] [Abstract][Full Text] [Related]
19. IGFBP-3 promotes cachexia-associated lipid loss by suppressing insulin-like growth factor/insulin signaling.
Wang X; Li J; Zhang W; Wang F; Wu Y; Guo Y; Wang D; Yu X; Li A; Li F; Xie Y
Chin Med J (Engl); 2023 Apr; 136(8):974-985. PubMed ID: 37014770
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics analysis reveals novel serum metabolite alterations in cancer cachexia.
More TH; Hiller K; Seifert M; Illig T; Schmidt R; Gronauer R; von Hahn T; Weilert H; Stang A
Front Oncol; 2024; 14():1286896. PubMed ID: 38450189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
